DK1017675T3 - Stærkt lipofile camptothecinderivater - Google Patents

Stærkt lipofile camptothecinderivater

Info

Publication number
DK1017675T3
DK1017675T3 DK98904990T DK98904990T DK1017675T3 DK 1017675 T3 DK1017675 T3 DK 1017675T3 DK 98904990 T DK98904990 T DK 98904990T DK 98904990 T DK98904990 T DK 98904990T DK 1017675 T3 DK1017675 T3 DK 1017675T3
Authority
DK
Denmark
Prior art keywords
derivatives
camptothecin derivatives
strongly lipophilic
lipophilic camptothecin
substitution
Prior art date
Application number
DK98904990T
Other languages
Danish (da)
English (en)
Inventor
Frederick H Hausheer
Kochat Haridas
Dasharatha G Reddy
Shijie Yao
Dhanabalan Murali
P Seetharamulu
Pavankumar N V Petluru
Original Assignee
Bionumerik Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionumerik Pharmaceuticals Inc filed Critical Bionumerik Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1017675T3 publication Critical patent/DK1017675T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Silicon Polymers (AREA)
  • Saccharide Compounds (AREA)
DK98904990T 1997-02-14 1998-02-11 Stærkt lipofile camptothecinderivater DK1017675T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3714897P 1997-02-14 1997-02-14

Publications (1)

Publication Number Publication Date
DK1017675T3 true DK1017675T3 (da) 2006-10-16

Family

ID=21892705

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98904990T DK1017675T3 (da) 1997-02-14 1998-02-11 Stærkt lipofile camptothecinderivater

Country Status (10)

Country Link
EP (1) EP1017675B1 (ja)
JP (2) JP4311765B2 (ja)
AT (1) ATE329903T1 (ja)
AU (1) AU6272598A (ja)
CA (1) CA2280905C (ja)
DE (1) DE69834923T2 (ja)
DK (1) DK1017675T3 (ja)
ES (1) ES2262223T3 (ja)
PT (1) PT1017675E (ja)
WO (1) WO1998035940A1 (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743917B2 (en) 1993-06-30 2004-06-01 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US6136978A (en) * 1993-06-30 2000-10-24 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US6150343A (en) * 1993-06-30 2000-11-21 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
FR2790261B1 (fr) * 1999-02-26 2004-09-10 Sod Conseils Rech Applic Nouveaux analogues optiquement purs de la camptothecine et leurs procedes de preparation
WO1998035940A1 (en) * 1997-02-14 1998-08-20 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives
US6057303A (en) * 1998-10-20 2000-05-02 Bionumerik Pharmaceuticals, Inc. Highly lipophilic Camptothecin derivatives
US6207832B1 (en) 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
AU4822500A (en) * 1999-05-04 2000-11-17 Bionumerik Pharmaceuticals, Inc. Novel highly lipophilic camptothecin analogs
US6350756B1 (en) 2001-01-18 2002-02-26 California Pacific Medical Center Camptothecin derivatives
US6855720B2 (en) 2001-03-01 2005-02-15 California Pacific Medical Center Nitrogen-based camptothecin derivatives
US6372906B1 (en) 2001-04-12 2002-04-16 University Of Pittsburgh Synthesis of silyl camptothecins and silyl homocamptothecins
US6723853B2 (en) 2001-08-27 2004-04-20 University Of Pittsburgh Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins
RU2299212C2 (ru) 2001-11-30 2007-05-20 Чугаи Сейяку Кабусики Кайся Гексациклические соединения, фармацевтическая композиция, содержащая их и их применение в качестве противоопухолевых средств, способ получения гексациклических соединений
WO2003101998A1 (en) 2002-06-03 2003-12-11 California Pacific Medical Center Nitrogen-based homo-camptothecin derivatives
EP1393719A1 (en) * 2002-08-23 2004-03-03 Munich Biotech AG Camptothecin-carboxylate formulations
US7067666B2 (en) * 2003-06-27 2006-06-27 Research Triangle Institute 7-substituted camptothecin and camptothecin analogs and methods for producing the same
CN1893892B (zh) * 2003-12-17 2012-03-28 比奥纽默里克药物公司 喜树碱的药物制剂和制备它们的方法
CN1964979B (zh) 2004-04-09 2011-07-27 中外制药株式会社 新颖的水溶性前药
ITRM20040240A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
TW200744603A (en) 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
US7875602B2 (en) 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
TW200731990A (en) * 2005-12-16 2007-09-01 Sonus Pharma Inc Lipophilic anticancer drug compounds, compositions, and related methods
EP2049545B1 (en) * 2006-08-11 2012-05-16 CHRISTUS Stehlin Foundation for Cancer Research Methods of making esters of camptothecins
CN103068404B (zh) 2010-06-11 2015-11-25 独立行政法人科学技术振兴机构 药物多聚物微粒及其制造方法
EP2914600A2 (en) * 2012-10-30 2015-09-09 Nerviano Medical Sciences S.r.l. Functionalized 9-bromo-camptothecin derivatives
FR3029637B1 (fr) 2014-12-05 2018-01-05 Universite De Strasbourg Microdispositif de detection de composes organiques volatils et methode de detection d'au moins un compose organique volatil compris dans un echantillon gazeux
CN111194341B (zh) 2018-09-14 2022-09-23 美国陶氏有机硅公司 压敏粘合剂及其制备和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
US5446047A (en) * 1992-07-23 1995-08-29 Sloan-Kettering Institute For Cancer Research Camptothecin analogues
US5468754A (en) * 1994-04-19 1995-11-21 Bionumerik Pharmaceuticals, Inc. 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof
GB9510716D0 (en) * 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
WO1998035940A1 (en) * 1997-02-14 1998-08-20 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives

Also Published As

Publication number Publication date
JP2001511807A (ja) 2001-08-14
CA2280905A1 (en) 1998-08-20
WO1998035940A1 (en) 1998-08-20
AU6272598A (en) 1998-09-08
JP4311765B2 (ja) 2009-08-12
EP1017675A4 (en) 2001-08-22
ATE329903T1 (de) 2006-07-15
EP1017675A1 (en) 2000-07-12
DE69834923T2 (de) 2006-10-19
JP5264561B2 (ja) 2013-08-14
CA2280905C (en) 2006-08-29
EP1017675B1 (en) 2006-06-14
DE69834923D1 (en) 2006-07-27
ES2262223T3 (es) 2006-11-16
PT1017675E (pt) 2006-09-29
JP2009149680A (ja) 2009-07-09

Similar Documents

Publication Publication Date Title
DK1017675T3 (da) Stærkt lipofile camptothecinderivater
ATE261974T1 (de) Hoch-lipophile campothecin-derivate
EA200100111A1 (ru) Ингибиторы фарнезилпротеинтрансферазы, обладающие in vivo радиосенсибилизирующими свойствами
TR200000576T1 (tr) Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
EA200100954A1 (ru) Производные камптотецина, обладающие противоопухолевой активностью
CY1105803T1 (el) Συνθεση πepιλαμβανουσα καμπτοθεκινη και ενα παραγωγο πυριμιδινης για τη θepαπεια καρκινου
PT1212312E (pt) Novos derivados de flavonas xantonas e cumarinas
BG108072A (en) The use of epothilone derivatives for the treatment of refractory tumors
MX9307011A (es) Derivados hidrosolubles de camptotecina, proceso para su preparacion y composiciones farmaceuticas que los contienen.
HK1040983A1 (en) Quinones for treatment of diseases.
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
DE69921486D1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
DE69901506T2 (de) Verwendung von natriumchlorid zur verminderung der gastrointestinalen toxizität von camptotecinderivaten.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
HUP0302629A2 (hu) Camptotechin és sztilbénszármazékok kombinációját tartalmazó gyógyszerkészítmények rák kezelésére
SE9803107D0 (sv) Novel Compunds
SE9602262D0 (sv) New use of derivatives of cystine
ATE480522T1 (de) 9-alkylamino-1-nitroacridin-derivate